Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,263 shares at $292.68 ($2.7M) on 2023-03-10, disclosed to the SEC on 2023-03-14.
Open-market sale of $2.7M VRTX by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $286.64 | 361 | $103K | 3.8% |
| 2 | $286.64 | 361 | $103K | 3.8% |
| 3 | $287.83 | 515 | $148K | 5.5% |
| 4 | $287.83 | 515 | $148K | 5.5% |
| 5 | $288.91 | 327 | $94K | 3.5% |
| 6 | $288.91 | 327 |
| $94K |
| 3.5% |
| 7 | $289.44 | 30 | $9K | 0.3% |
| 8 | $291.47 | 541 | $158K | 5.8% |
| 9 | $291.47 | 541 | $158K | 5.8% |
| 10 | $292.68 | 185 | $54K | 2.0% |
| 11 | $292.68 | 185 | $54K | 2.0% |
| 12 | $293.61 | 27 | $8K | 0.3% |
| 13 | $294.94 | 102 | $30K | 1.1% |
| 14 | $288.31 | 24 | $7K | 0.3% |
| 15 | $292.41 | 420 | $123K | 4.5% |
| 16 | $292.41 | 420 | $123K | 4.5% |
| 17 | $293.35 | 1,153 | $338K | 12.5% |
| 18 | $293.35 | 1,153 | $338K | 12.5% |
| 19 | $294.52 | 715 | $211K | 7.8% |
| 20 | $294.52 | 715 | $211K | 7.8% |
| 21 | $295.89 | 292 | $86K | 3.2% |
| 22 | $295.89 | 292 | $86K | 3.2% |
| 23 | $296.77 | 62 | $18K | 0.7% |
| Total | $291.92 avg | 9,263 | $2.7M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |